W celu świadczenia usług na najwyższym poziomie stosujemy pliki cookies. Korzystanie z naszej witryny oznacza, że będą one zamieszczane w Państwa urządzeniu. W każdym momencie można dokonać zmiany ustawień Państwa przeglądarki. Zobacz politykę Cookies
X

News

Position of the Transparency Council – Suliqua (insulinum glarginum + lixisenatidum)

more...

Position of the Transparency Council – Onureg (azacitidine)

more...

Communication on the meeting of the Tariff Council on 28.07.2022

more...

Communication on the meeting of the Tariff Council on 21.07.2022

more...

More than PLN 18 billion for, among other things, minimum wage increases. Additionally, an increase in the lump sum payment and higher valuation of internal medicine healthcare services

more...

Press conference – implementation of the Act on the manner of determining the lowest basic salary for employees employed in healthcare entities

more...

The Meeting of the Transparency Council No. 32/2022 of 16.08.2022

more...

Communication – Data acquisition for gastroscopy performed in outpatient settings

more...

The Meeting of the Transparency Council No. 31/2022 of 11.08.2022

more...

The Meeting of the Tariffs Council No. 19/2022 of 11.08.2022

more...

Opinion of the President – Breast cancer prevention programme – ultrasound examination for women aged 30 to 49 from the town of Sieradz

more...

The Meeting of the Transparency Council No. 30/2022 of 01.08.2022.

more...

Recommendation of the President – Yervoy (ipilimumab) in combination with Opdivo (nivolumab)

more...

Recommendation of the President – Opdivo (nivolumab) in combination with Yervoy (ipilimumab)

more...

Opinion of the Transparency Council – health policy programme on therapeutic rehabilitation (town of Żyrardów)

more...

Opinion of the Transparency Council – health policy programme on breast cancer prevention (town of Sieradz)

more...

Opinion of the Transparency Council – changes to the drug programme B.61

more...

Opinion of the Transparency Council – active substance ipratropii bromidum

more...

Opinion of the Transparency Council – active substances fenoteroli hydrobromidum + ipratropii bromidum

more...

Opinion of the Transparency Council – active substance prednisone

more...

Opinion of the Transparency Council – active substances amiloridum + hydrochlorothiazidum

more...

Opinion of the Transparency Council – health policy programme on medical rehabilitation (Municipality of Mielno)

more...

Opinion of the Transparency Council – health policy programme on detection of vision defects (Municipality of Chociwel)

more...

Opinion of the Transparency Council – health policy programme on detection of vision defects (town of Będzin)

more...